Literature DB >> 24740557

Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.

Kazutoshi Fujita1, Motohide Uemura, Yoshiyuki Yamamoto, Go Tanigawa, Wataru Nakata, Mototaka Sato, Akira Nagahara, Hiroshi Kiuchi, Yasutomo Nakai, Kiyomi Matsumiya, Seiji Yamaguchi, Norio Nonomura.   

Abstract

BACKGROUND: This study aimed to identify preoperative parameters for predicting cancer-specific survival (CSS) in patients with upper urinary tract urothelial carcinoma (UTUC) who have undergone radical nephroureterectomy (RNU).
METHODS: The preoperative clinical and laboratory records of 357 UTUC patients who underwent RNU at three different institutions were retrospectively reviewed (256, training set; 101, test set). Univariate and multivariate analyses were performed on the training set data to identify preoperative prognostic factors, using which a risk stratification model was developed. The model was validated using test set data.
RESULTS: In univariate analysis, clinical T stage classification and preoperative concentrations of hemoglobin, C-reactive protein, sodium, and albumin showed significant association with CSS. Multivariate analysis showed that low preoperative sodium and hemoglobin concentrations were significantly associated with a poor prognosis. A risk stratification model was developed using the preoperative sodium (<141 mEq/L) and hemoglobin concentrations (below normal). Three subgroups were formed depending on the presence of no (favorable group), one (intermediate), or two (poor) prognostic factors, and the 5-year CSS estimates were found to be 96.5, 75.5, and 47.0 %, respectively (P < 0.01). The risk model was significantly associated with the adverse pathological findings of stage pT3 or more and lymphovascular invasion (P = 0.005).
CONCLUSION: We identified low preoperative sodium and hemoglobin concentrations as prognostic factors for patients with UTUC treated with RNU. Our risk stratification model may help physicians design a therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740557     DOI: 10.1007/s10147-014-0695-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  20 in total

1.  Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.

Authors:  Bulent Akdogan; Hasan Serkan Dogan; Saadettin Yilmaz Eskicorapci; Ahmet Sahin; Ilhan Erkan; Haluk Ozen
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Jun Obata; Eiji Kikuchi; Nobuyuki Tanaka; Kazuhiro Matsumoto; Nozomi Hayakawa; Hiroki Ide; Akira Miyajima; Ken Nakagawa; Mototsugu Oya
Journal:  Urol Oncol       Date:  2012-11-08       Impact factor: 3.498

3.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

4.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

Authors:  Matthew G Kaag; Rebecca L O'Malley; Padraic O'Malley; Guilherme Godoy; Mang Chen; Marc C Smaldone; Ronald L Hrebinko; Jay D Raman; Bernard Bochner; Guido Dalbagni; Michael D Stifelman; Samir S Taneja; William C Huang
Journal:  Eur Urol       Date:  2010-06-25       Impact factor: 20.096

5.  Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma.

Authors:  M J Scolieri; M L Paik; S L Brown; M I Resnick
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

Review 6.  The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).

Authors:  François Audenet; David R Yates; Olivier Cussenot; Morgan Rouprêt
Journal:  Urol Oncol       Date:  2010-09-29       Impact factor: 3.498

Review 7.  Anemia in cancer.

Authors:  M Dicato; L Plawny; M Diederich
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

8.  Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma.

Authors:  Kang Su Cho; Sung Joon Hong; Nam Hoon Cho; Young Deuk Choi
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

9.  Generation of a concise gene panel for outcome prediction in urinary bladder cancer.

Authors:  Anirban P Mitra; Vincenzo Pagliarulo; Dongyun Yang; Frederic M Waldman; Ram H Datar; Donald G Skinner; Susan Groshen; Richard J Cote
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

10.  Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?

Authors:  Casey K Ng; Shahrokh F Shariat; Steven M Lucas; Aditya Bagrodia; Yair Lotan; Douglas S Scherr; Jay D Raman
Journal:  Urol Oncol       Date:  2008-12-30       Impact factor: 3.498

View more
  16 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.

Authors:  T Grimm; A Buchner; B Schneevoigt; A Kretschmer; M Apfelbeck; M Grabbert; J F Jokisch; C G Stief; A Karl
Journal:  World J Urol       Date:  2015-09-16       Impact factor: 4.226

3.  A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.

Authors:  Mesut Altan; Hakan Bahadır Haberal; Bülent Akdoğan; Haluk Özen
Journal:  Int J Clin Oncol       Date:  2017-06-09       Impact factor: 3.402

4.  Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.

Authors:  Jing Xie; Xue-Bin Zhang; Jin Wen; Yu-Shi Zhang; Han-Zhong Li
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

5.  SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.

Authors:  Li-Jung Ma; Wen-Jen Wu; Yu-Hui Wang; Ting-Feng Wu; Peir-In Liang; I-Wei Chang; Hong-Lin He; Chien-Feng Li
Journal:  J Cancer       Date:  2016-01-29       Impact factor: 4.207

Review 6.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

Review 7.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

Review 8.  Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.

Authors:  Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-01-31

9.  Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.

Authors:  Kazutoshi Fujita; Kei Taneishi; Teruo Inamoto; Yu Ishizuya; Shingo Takada; Masao Tsujihata; Go Tanigawa; Noriko Minato; Shigeaki Nakazawa; Tsuyoshi Takada; Toshichika Iwanishi; Motohide Uemura; Yasushi Okuno; Haruhito Azuma; Nonomura Norio
Journal:  BMC Urol       Date:  2017-12-01       Impact factor: 2.264

10.  The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.

Authors:  Teruo Inamoto; Hideyasu Matsuyama; Shigeru Sakano; Naokazu Ibuki; Kiyoshi Takahara; Kazumasa Komura; Tomoaki Takai; Takuya Tsujino; Yuki Yoshikawa; Koichiro Minami; Kazuhiro Nagao; Ryo Inoue; Haruhito Azuma
Journal:  Oncotarget       Date:  2017-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.